A Study of ZW25 With Palbociclib Plus Fulvestrant in Patients With HER2+/HR+ Advanced Breast Cancer

Condition:   HER2+/HR+ Breast Cancer Interventions:   Drug: ZW25;   Drug: Palbociclib;   Drug: Fulvestrant Sponsor:   Zymeworks Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials